---
document_datetime: 2025-05-02 15:59:55
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/eptifibatide-accord-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: eptifibatide-accord-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.707584
conversion_datetime: 2025-12-28 17:25:00.648061
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Eptifibatide Accord

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, please also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                               | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|-------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Article 61(3) /      | - Notification acc. Article 61(3) - | 02/05/2025                          |                                             | PL                               |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/N/0000267275                         | Update of the package leaflet to introduce a list of local representatives.                                                                                                                                                                                                                                                                                                                                                                                                                  |            |     |                 |
|------------------------------------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|-----------------|
| Variation type II / EMA/VR/0000244821    | This was an application for a group of variations. B.II.b.4 Change in the batch size (including batch size ranges) of the finished product - B.II.b.4.d The change relates to all other pharmaceutical forms manufactured by complex manufacturing processes - Accepted B.II.b.4 Change in the batch size (including batch size ranges) of the finished product - B.II.b.4.d The change relates to all other pharmaceutical forms manufactured by complex manufacturing processes - Accepted | 20/03/2025 | N/A |                 |
| Variation type IA_IN / EMA/VR/0000254111 | This was an application for a group of variations. B.II.b.1 Replacement or addition of a manufacturing site for part or all of the manufacturing process of the finished product - B.II.b.1.a Secondary packaging site - Accepted B.II.b.2.c Replacement or addition of a manufacturer responsible for importation and/or batch release - B.II.b.2.c.2 Including                                                                                                                             | 24/02/2025 | N/A | Annex II and PL |

<div style=\"page-break-after: always\"></div>

|                                       | batch control/testing - Accepted                                                                                                                                                                                                                                                                                                  |            |     |
|---------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|
| Variation type IB / EMA/VR/0000244815 | B.II.b.3 Change in the manufacturing process of the finished product, including an intermediate used in the manufacture of the finished product - B.II.b.3.a Minor change in the manufacturing process - Accepted                                                                                                                 | 06/02/2025 | N/A |
| Variation type IA / EMA/VR/0000233760 | A. ADMINISTRATIVE CHANGES - A.7 Deletion of manufacturing sites for an active substance, intermediate or finished product, packaging site, manufacturer responsible for batch release, site where batch control takes place, or supplier of a starting material, reagent or excipient (when mentioned in the dossier)* - Accepted | 14/11/2024 | N/A |